| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |